Evidence map›Paper›PMID 41014560›Full record

ArticleCell reports2025

In vitro protocol demonstrating five functional steps of trained immunity in mice: Implications on biomarker discovery and translational research.

Maria González-Pérez, Jana Baranda, Leticia Pérez-Rodríguez, Patricia Conde, Carlos de la Calle-Fabregat, Marcos J Berges-Buxeda, Alexander Dimitrov, Javier Arranz, Sergio Rius-Rocabert, Alessia Zotta and 12 more

Abstract read
In one paragraph

Article in Cell reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Review
  2. Review
  3. Article
  4. Article
  5. Article
  6. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

22 authors.

Maria González-PérezNational Microbiology Center, National Institutes of Health Carlos III, Madrid, Spain; Department of Pharmaceutical Sciences, CEU-San Pablo University, Madrid, Spain.
Jana BarandaNational Microbiology Center, National Institutes of Health Carlos III, Madrid, Spain; Department of Pharmaceutical Sciences, CEU-San Pablo University, Madrid, Spain.
Leticia Pérez-RodríguezDepartment of Oncological Sciences and Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
Patricia CondeNational Microbiology Center, National Institutes of Health Carlos III, Madrid, Spain.
Carlos de la Calle-FabregatInstitut National de la Santé Et de la Recherche Médicale (INSERM) U1015, Gustave Roussy Cancer Campus, Villejuif, France.
Marcos J Berges-BuxedaNational Microbiology Center, National Institutes of Health Carlos III, Madrid, Spain.
Alexander DimitrovDepartment of Oncological Sciences and Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
Javier ArranzNational Microbiology Center, National Institutes of Health Carlos III, Madrid, Spain; Department of Pharmaceutical Sciences, CEU-San Pablo University, Madrid, Spain.
Sergio Rius-RocabertDepartment of Pharmaceutical Sciences, CEU-San Pablo University, Madrid, Spain.
Alessia ZottaSchool of Biochemistry and Immunology, Trinity Biomedical Sciences Institute, Trinity College Dublin, Dublin, Ireland.
Ana DopazoGenomics Unit, National Cardiovascular Center (CNIC), Madrid, Spain.
Nikita PoddarTisch Cancer Institute Bioinformatics for Next Generation Sequencing, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
Xuedi WangTisch Cancer Institute Bioinformatics for Next Generation Sequencing, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
Estanislao Nistal-VillánDepartment of Pharmaceutical Sciences, CEU-San Pablo University, Madrid, Spain.
Raphaël DuivenvoordenDepartment of Nephrology, Radboud University Medical Center, Nijmegen, the Netherlands; Biomolecular Engineering and Imaging Institute, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
Joren C MadsenCenter for Transplantation Sciences and Division of Cardiac Surgery, Department of Surgery, Massachusetts General Hospital, Boston, MA, USA.
David L WilliamsDepartment of Surgery and Center for Inflammation, Infectious Disease and Immunity, East Tennessee State University, Johnson City, TN, USA.
Dan HassonDepartment of Oncological Sciences and Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY, USA; Tisch Cancer Institute Bioinformatics for Next Generation Sequencing, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
Daniel Lozano-OjalvoImmunology Institute, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
Florent GinhouxInstitut National de la Santé Et de la Recherche Médicale (INSERM) U1015, Gustave Roussy Cancer Campus, Villejuif, France.
Luke A J O'NeillSchool of Biochemistry and Immunology, Trinity Biomedical Sciences Institute, Trinity College Dublin, Dublin, Ireland.
Jordi OchandoNational Microbiology Center, National Institutes of Health Carlos III, Madrid, Spain; Department of Oncological Sciences and Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY, USA; Immunology Institute, Icahn School of Medicine at Mount Sinai, New York, NY, USA. Electronic address: jordi.ochando@mssm.edu.

Funding

Conduits: Mount Sinai Health System Translational Science HubUL1TR004419 · NCATS · ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI · PI Rosalind J Wright · 2022 to 2026
$46.4M
THE TISCH CANCER INSTITUTE - CANCER CENTER SUPPORT GRANTP30CA196521 · NCI · ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI · PI Ramon E Parsons · 2015 to 2026
$35.4M
Using trained immunity-inhibiting nanobiologics to achieve tolerance of heart allografts in non-human primatesP01AI168258 · NIAID · ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI · PI Zahi A. Fayad, Joren C Madsen · 2023 to 2026
$14.7M
National Metabolomics Data Repository - nextgen Metabolomics WorkbenchU2CDK119886 · NIDDK · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI SUBRAMANIAM, SHANKAR · 2018 to 2021
$12.7M
Training Innate Immunity: A new approach to the treatment of SepsisR01GM119197 · NIGMS · EAST TENNESSEE STATE UNIVERSITY · PI SHERWOOD, EDWARD R, WILLIAMS, DAVID L. · 2016 to 2024
$4.6M
Biomedical Data Commons Workbench (BDCW)OT2OD030544 · OD · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI SUBRAMANIAM, SHANKAR · 2020 to 2024
$3.2M
COVID and Translational Science supercomputer (CATS)S10OD030463 · OD · ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI · PI KOVATCH, PATRICIA · 2021 to 2021
$2.0M
Big Omics Data Engine 2 SupercomputerS10OD026880 · OD · ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI · PI KOVATCH, PATRICIA · 2019 to 2019
$2.0M
Glucan glycomimetics: A new approach to stimulating innate immune trainingR21AI176153 · NIAID · EAST TENNESSEE STATE UNIVERSITY · PI WILLIAMS, DAVID L. · 2024 to 2025
$415k
NCATS NIH HHS UL1 TR004419NCI NIH HHS P30 CA196521NIAID NIH HHS P01 AI168258NIAID NIH HHS R21 AI176153NIDDK NIH HHS U2C DK119886NIGMS NIH HHS R01 GM119197NIH HHS OT2 OD030544NIH HHS S10 OD026880NIH HHS S10 OD030463
6 · The paper itself

Abstract

We developed an in vitro methodology to study trained immunity using murine bone-marrow-derived macrophages stimulated with β-glucan and lipopolysaccharide (LPS). Longitudinal analysis of interleukin (IL)-6 and tumor necrosis factor (TNF) production demonstrates that trained macrophages secrete higher cytokine levels following primary stimulation with β-glucan compared to unstimulated macrophages (step 1). After a resting period, trained macrophages return to basal levels of cytokine production (step 2) but rapidly produce enhanced levels of IL-6 and TNF after secondary stimulation with LPS, compared to macrophages individually stimulated with either β-glucan (step 3) or LPS (step 4) alone. The combined cytokine production of macrophages after single stimulation with β-glucan (stimulus 1) and LPS (stimulus 2) is significantly lower than the cytokine levels produced by trained macrophages sequentially stimulated with both β-glucan and LPS (stimulus 1 + 2) (step 5). These results experimentally reproduce the distinctive functional stages that macrophages undergo during the training process.

Indexed as

BiomarkersMacrophagesTranslational Research, BiomedicalAnimalsbeta-GlucansCytokinesInterleukin-6LipopolysaccharidesMaleMiceMice, Inbred C57BLTrained ImmunityTumor Necrosis Factor-alphabeta-GlucansBiomarkersCytokinesInterleukin-6LipopolysaccharidesTumor Necrosis Factor-alphaCP: Immunologymouse strainsmTORSAA3sample cryopreservationT cell proliferationtrained immunity

Identifiers

PMID41014560
PMCPMC12805498

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.